Table 1 Population characteristics according to the presence or absence of CAD

Gender (men/women)

178/94

39/39

139/55^aa

Age (years)

65.7 ± 10.2

62.4 ± 10.0

67.0 ± 10.1^aa

BMI (kg/m²)

24.8 ± 3.1

25.2 ± 3.2

24.6 ± 3.1

W (cm)

90.4 ± 9.2

90.1 ± 9.4

90.5 ± 9.1

SBP (mmHg)

130 (120-148)

130 (120-143)

130 (120-150)

DBP (mmHg)

80 (70-85)

80 (70-88)

80 (70-83)

FPG (mmol/L)

5.4 (5.0-6.3)

5.5 (5.1-6.0)

5.4 (5.0-6.5)

2hPG (mmol/L)

8.6 (6.7-11.8)

8.1 (6.0-9.9)

8.8 (6.7-12.5)^a

HbA1c (%)

6.2 (5.7-6.8)

5.9 (5.6-6.4)

6.2 (5.8-7.0)^aa

GA (%)

16.0 (14.0-19.0)

15.0 (13.0-17.0)

16.0 (15.0-19.0)^aa

1,5-AG (μg/mL)

21.7 ± 10.1

23.9 ± 9.8

20.8 ± 10.1^a

TC (mmol/L)

4.4 ± 1.1

4.6 ± 1.0

4.3 ± 1.1^a

TG (mmol/L)

1.5 (1.1-2.2)

1.6 (1.1-2.3)

1.5 (1.1-2.1)

HDL-c (mmol/L)

1.1 (0.9-1.3)

1.1 (0.9-1.3)

1.0 (0.9-1.3)

LDL-c (mmol/L)

3.0 ± 0.9

3.1 ± 0.8

3.0 ± 1.0

eGFR (mL/min/1.73 m²)

89.0 ± 23.6

92.2 ± 24.9

87.8 ± 23.0

CRP (mg/L)

1.2 (0.6-3.1)

1.4 (0.5-3.1)

1.2 (0.6-2.9)

HOMA-IR

4.0 (2.8-5.9)

3.9 (2.8-5.9)

4.0 (2.8-6.1)

CSI

6 (2-12)

0 (0-1)

9 (4-14)^aa

Smoking, n (%)

121 (44.5)

29 (37.2)

92 (47.4)

Diabetes ratio, n (%)

110 (40.4)

24 (30.8)

86 (44.3)^a

Family history of CAD, n (%)

116 (42.6)

38 (48.7)

78 (40.2)

Hypoglycemic therapy, n (%)

62 (22.8)

11 (14.1)

51 (26.3)^a

Anti-hypertensive therapy, n (%)

185 (68.0)

51 (65.4)

134 (69.1)

Lipid-lowering therapy, n (%)

76 (27.9)

11 (14.1)

65 (33.5)^aa